The NADPH Oxidase inhibitor Diapocynin Prevents Parkinson's Disease Symptoms in the Leucine-Rich Repeat Kinase 2 (LRRK2R1441G) Transgenic Mouse

被引：0
|
作者：
Dranka, Brian P. [1 ]
Gifford, Alison [1 ]
Ghosh, Anamitra [2 ]
Kanthasamy, Anumantha G. [2 ]
Kalyanaraman, Balaraman [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI USA
[2] Iowa State Univ, Ames, IA USA
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2012年 / 53卷
关键词：
D O I：
10.1016/j.freeradbiomed.2012.10.194
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R1441G) transgenic mouse
    Dranka, Brian P.
    Gifford, Alison
    Ghosh, Anamitra
    Zielonka, Jacek
    Joseph, Joy
    Kanthasamy, Anumantha G.
    Kalyanaraman, Balaraman
    NEUROSCIENCE LETTERS, 2013, 549 : 57 - 62
  • [2] The NADPH Oxidase Inhibitor Apocynin Improves Motor Function in the Leucine-Rich Repeat Kinase 2 (LRRK2R1441G) Transgenic Mouse
    Dranka, Brian P.
    Gifford, Alison
    Kanthasamy, Anumantha G.
    Kalyanaraman, B.
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 51 : S69 - S70
  • [3] A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2R1441G) transgenic mouse model of Parkinson's disease
    Dranka, Brian P.
    Gifford, Alison
    McAllister, Donna
    Zielonka, Jacek
    Joseph, Joy
    O'Hara, Crystal L.
    Stucky, Cheryl L.
    Kanthasamy, Anumantha G.
    Kalyanaraman, Balaraman
    NEUROSCIENCE LETTERS, 2014, 583 : 159 - 164
  • [4] A Novel Mitochondrially-Targeted Apocynin Derivative Prevents Hyposmia and Loss of Motor Function in the Leucine-Rich Repeat Kinase 2 (LRRK2R1441G) Transgenic Mouse Model of Parkinson's Disease
    Dranka, Brian P.
    Gifford, Alison
    McAllister, Donna
    Zielonka, Jacek
    Joseph, Joy
    Kalyanaraman, Balaraman
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 65 : S45 - S45
  • [5] Transgenic LRRK2R1441G rats-a model for Parkinson disease?
    Shaikh, Komal T.
    Yang, Alvin
    Youshin, Ekaterina
    Schmid, Susanne
    PEERJ, 2015, 3
  • [6] The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
    Cookson, Mark R.
    NATURE REVIEWS NEUROSCIENCE, 2010, 11 (12) : 791 - 797
  • [7] The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
    Mark R. Cookson
    Nature Reviews Neuroscience, 2010, 11 : 791 - 797
  • [8] Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease
    Domingos, Sofia
    Duarte, Teresa
    Saraiva, Lucilia
    Guedes, Rita C.
    Moreira, Rui
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (15) : 1953 - 1977
  • [9] Leucine-rich repeat kinase 2 and Parkinson's disease
    Kang, Un-Beom
    Marto, Jarrod A.
    PROTEOMICS, 2017, 17 (1-2)
  • [10] Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
    Yanping Li
    Wencheng Liu
    Tinmarla F Oo
    Lei Wang
    Yi Tang
    Vernice Jackson-Lewis
    Chun Zhou
    Kindiya Geghman
    Mikhail Bogdanov
    Serge Przedborski
    M Flint Beal
    Robert E Burke
    Chenjian Li
    Nature Neuroscience, 2009, 12 : 826 - 828
12345